Worker's Compensation


CD52 Monoclonal Antibodies

Lemtrada (alemtuzumab)

Alemtuzumab is a drug used in the treatment of chronic lymphocytic leukemia (CLL), cutaneous T-cell lymphoma (CTCL) and T-cell lymphoma under the trade names Campath, MabCampath and Campath-1H, and in the treatment of multiple sclerosis as Lemtrada. It is also used in some conditioning regimens for bone marrow transplantation, kidney transplantation and islet cell transplantation....Wikipedia


Manufacturer's Website: Lemtrada                                                                                                                   Average retail cost: $22,200/vial

Copyright 2006-2023 Automated Clinical Guidelines, LLC. All rights reserved.

Home  Contact  FAQ